As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times. Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.
COVID-19 and impact on peer review
Journal of Pharmaceutical Policy and Practice is now the official journal of the Commonwealth Pharmacists Association
BMC is pleased to announce that JoPPP is now the official journal of the Commonwealth Pharmacists Association (CPA). This newly formed partnership will further both groups' desire to promote research in pharmacy and global health.
The CPA is a registered charity that advances health, promotes wellbeing, and improves education for the benefit of people of the Commonwealth. Their vision is to empower pharmacists to improve health and wellbeing throughout the Commonwealth, with a key focus on supporting and optimising medicines use in the Commonwealth particularly in low-middle income countries.
For more information on this partnership and the society, please see the CPA's press release announcing the relationship.
Call for Papers: Thematic series on COVID-19
The Journal of Pharmaceutical Policy and Practice would like to announce a Call for Papers for a special series on COVID-19.
The journal seeks works related to prevention, newer treatments, medicines safety, medicines quality and shortages, pharmaceutical policy and practice, pharmacists and pharmacy services, information and dissemination, as well as technology aspects of COVID-19.
More information on this series can be found here.
This editorial, which begins our thematic series related to the COVID-19 pandemic, highlights the many roles pharmacists will play in combating this disease. Examples from the UK and Pakistan are discussed, and guidelines and practices are provided that could be applied to any country.
Collections and Thematic Series
Click here to see our earlier collections and thematic collections.
Uniquely positioned as an interactive platform for pioneering pharmaceutical policy research in developed and developing countries, Journal of Pharmaceutical Policy and Practice disseminates empirical research in all aspects of pharmacy including clinical, social, administrative or economic. Dedicated to furthering our vision that people everywhere should have access to the medicines they need and use them rationally, we share new evidence, key issues and perspectives in pharmaceutical policy and practice from researchers, academics and practitioners at local and global levels.
This is a cross-journal series to highlight the challenges and developments within antimicrobial drug policies in low and middle income countries. Both reviews and original research articles are welcome.
Submit to the series here.
We are pleased to announce this years joint winners of the 2019 Helen Clark-JoPPP Award for Pharmaceutical Policy and Practice Research. Both winners have made significant contributions to the field, and their work has been judged both on its scientific merit, as well as its impact on patients, decisions makers and on the government policies. Please join us in congratulating Dr Margaret Ewen and Dr Sabine Vogler.
'On Health' blog
Zaheer-Ud-Din Babar is Professor in Medicines and Healthcare at the Department of Pharmacy, University of Huddersfield, United Kingdom.
He is globally recognized for his research in pharmaceutical policy and practice, including the quality use of medicines, clinical pharmacy practice, access to medicines and issues related to pharmacoeconomics. Previously he was the Head of Pharmacy Practice at School of Pharmacy, Faculty of Medical and Health Sciences, University of Auckland, New Zealand. A pharmacist by training and a Ph.D. in pharmacy practice, Dr. Babar is the recipient of prestigious “Research Excellence Award” from the University of Auckland.
In December 2008, Southern Med Review was started by Dr Zaheer Babar to promote pharmaceutical policy research at a global level. It was a biannual publication, and it published more than 70 papers till December 2012, with authors from 45 countries. The journal has been unique in publishing the work of new researchers, documenting the pharmaceutical situation of low- and middle-income countries and debating pertinent pharmaceutical policy questions. The journal's work has been recognized at a global level and, according to WHO, it fulfilled a global need. For example, published studies have been instrumental in changing medicines policies in certain regions, especially in Vietnam and Thailand. The journal is indexed in Scopus, EMBASE and PubMed Central and in 2013 has been relaunched as Journal of Pharmaceutical Policy and Practice by BioMed Central.
Journal of Pharmaceutical Policy and Practice is affiliated with The University of Auckland and Auckland UniServices Ltd.
An electronic archive of content under the journal's previous name Southern Med Review (2009-2012) can be found on PubMed Central.
Annual Journal Metrics
76 days to first decision for reviewed manuscripts only
59 days to first decision for all manuscripts
176 days from submission to acceptance
60 days from acceptance to publication
235 Altmetric mentions